Termination by the Institution or the Investigator Sample Clauses

Termination by the Institution or the Investigator. Either the Institution or the Investigator may terminate this Agreement with immediate effect: (i) if PSI breaches this Agreement and fails to cure such breach within thirty (30) calendar days from the receipt of written notice; or (ii) if the Institution and/or the Investigator in good faith, and after consultation with the Sponsor, believe that the continuation of the Study presents an unreasonable medical risk to the Study subjects.
AutoNDA by SimpleDocs
Termination by the Institution or the Investigator. Either the Institution or the Investigator may terminate this Agreement with immediate effect: (i) if PSI breaches this Agreement and fails to cure such breach within thirty (30) calendar days from the receipt of written notice; or (ii) if the Institution and/or the Investigator in good faith believe that the continuation of the Study presents an unreasonable medical risk to the Study subjects. No indemnity of whatever sort shall be due by PSI or Sponsor as a consequence of such early termination. PSI shall pay for the work actually performed at the date of notice of termination. If this Agreement is terminated prior to the completion of the Study, the Institution and the Investigator will be given any necessary instructions concerning final examinations and final reporting that are required under the circumstances, and the Institution and the Investigator will comply with such instructions.
Termination by the Institution or the Investigator. Either the Institution or the Investigator may terminate this Agreement with immediate effect: (i) if the Sponsor breaches this Agreement and fails to cure such breach within thirty (30) calendar days from the receipt of written notice; or (ii) if the Institution and/or the Investigator in good faith believe that the continuation of the Study presents an unreasonable medical risk to the Study subjects. Zadavatel smí ukončit tuto Smlouvu s okamžitou platností, (i) pokud u Poskytovatel a/nebo Hlavní zkoušející poruší tuto Smlouvu a nezjedná nápravu do tiiceti (30) kalendáiních dnů od obdržení písemného upozornění, (ii) pokud se Zadavatel bude v dobré víie domnívat, že Studijní lék nebo pokračování ve Studii piedstavuje nepiiměiené zdravotní riziko pro Subjekty hodnocení, nebo pokud budou mít obavy ohledně účinnosti či bezpečnosti Studijního léku, nebo (iii) pokud bude Studie z jakéhokoli důvodu u Poskytovatele pierušena nebo nebude zahájena; nebo (iv) pokud Zadavatel zastaví, pieruší nebo odloží vývoj svého Studijního léku; nebo (v) z jakýchkoliv technických, regulačních nebo právních důvodů.
Termination by the Institution or the Investigator. Either the Institution or the Investigator may terminate this Agreement with immediate effect: (i) if the Sponsor breaches this Agreement and fails to cure such breach within thirty (30) calendar days Zadavatel smí ukončit tuto Xxxxxxx s okamžitou platností, (i) pokud Poskytovatel zdravotních služeb a/nebo Hlavní zkoušející poruší tuto Smlouvu a nezjedná nápravu do třiceti (30) kalendářních dnů od obdržení písemného upozornění, (ii) pokud se Zadavatel bude v dobré víře domnívat, že Studijní lék nebo pokračování ve Studii představuje nepřiměřené zdravotní riziko pro Subjekty hodnocení, nebo pokud bude mít obavy ohledně účinnosti či bezpečnosti Studijního léku, (iii) pokud bude Studie z jakéhokoli důvodu u Poskytovatele zdravotních služeb přerušena, nebo nebude zahájena.
Termination by the Institution or the Investigator. Ukončení zdravotnickým zařízením nebo zkoušejícím
Termination by the Institution or the Investigator. Either the Institution or the Investigator may terminate this Agreement with immediate effect: (i) if PSI breaches this Agreement and fails to cure such breach within thirty (30) calendar days from the receipt of written notice; or (ii) if the Institution and/or the Investigator in good faith, and after consultation with the Sponsor, believe that the continuation of the Study presents an unreasonable medical risk to the Study subjects. PSI smí po dohodě se Zadavatelem ukončit tuto Xxxxxxx s okamžitou platností, (i) pokud Zdravotnické zařízení a/nebo Hlavní zkoušející podstatně a opakovaně poruší tuto Smlouvu, Protokol nebo Platné regulační požadavky a nezjednají nápravu do třiceti (30) kalendářních dnů od obdržení písemného upozornění, (ii) pokud se PSI nebo Zadavatel budou v dobré víře domnívat, že Studijní lék nebo pokračování ve Studii představuje nepřiměřené zdravotní riziko pro Subjekty hodnocení, nebo pokud budou mít obavy ohledně účinnosti či bezpečnosti Studijního léku, (iii) pokud bude Studie z jakéhokoli důvodu ve Zdravotnickém zařízení přerušena, nebo nebude zahájena, nebo (iv) pokud dojde k ukončení Smlouvy týkající se Studie uzavřené mezi PSI a Zadavatelem, nebo (v) pokud nastanou kterékoli okolnosti uvedené v Oddílu 9. Nevyloučení a 10. Protiúplatková a protikorupční ustanovení. PSI smí též po dohodě se Zadavatelem ukončit tuto Xxxxxxx bez uvedení důvodu s výpovědní lhůtou třicet
Termination by the Institution or the Investigator. Either the Institution or the Investigator may terminate this Agreement with immediate effect: (i) if PSI breaches this Agreement and fails to PSI smí po dohodě se Zadavatelem ukončit tuto Xxxxxxx s okamžitou platností, (i) pokud Poskytovatel a/nebo Hlavní zkoušející poruší tuto Smlouvu, Protokol nebo Platné regulační požadavky a nezjednají nápravu do třiceti (30) kalendářních dnů od obdržení písemného upozornění, (ii) pokud se PSI nebo Zadavatel budou v dobré víře domnívat, že Studijní lék nebo pokračování ve Studii představuje nepřiměřené zdravotní riziko pro Subjekty hodnocení, nebo pokud budou mít obavy ohledně účinnosti či bezpečnosti Studijního léku,
AutoNDA by SimpleDocs

Related to Termination by the Institution or the Investigator

  • Clean-Up Terminations by the Sellers (a) The Sellers shall have the right to elect to terminate this Agreement in the event that the remaining Serviced Appointments have generated LTM Fee Revenue that is less than 5% of the aggregate fee revenue generated by all Appointments that are Serviced Appointments as of January 1, 2024 in the twelve-month period prior to January 1, 2024. (b) In the event the Sellers elect to terminate this Agreement pursuant to clause (a) above, the Sellers shall, concurrently with such termination, pay to the Purchasers an amount equal to LTM Fee Revenue multiplied by 1.40. (c) For purposes of this Agreement, “LTM Fee Revenue” means the fee revenue (excluding net interest income but including money market fund fees) generated by all remaining Serviced Appointments in the last full twelve-month period prior to the time the Sellers elect to exercise their termination right pursuant to this Section 7.2.2.

  • Indemnification by the Investor In consideration of the Company’s execution and delivery of this Agreement, and in addition to all of the Investor’s other obligations under this Agreement, the Investor shall defend, protect, indemnify and hold harmless the Company and all of its officers, directors, shareholders, employees and agents (including, without limitation, those retained in connection with the transactions contemplated by this Agreement) and each person who controls the Investor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively, the “Company Indemnitees”) from and against any and all Indemnified Liabilities incurred by the Company Indemnitees or any of them as a result of, or arising out of, or relating to (a) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement for the registration of the Shares as originally filed or in any amendment thereof, or in any related prospectus, or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; provided, however, that the Investor will only be liable for written information relating to the Investor furnished to the Company by or on behalf of the Investor specifically for inclusion in the documents referred to in the foregoing indemnity, and will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Investor by or on behalf of the Company specifically for inclusion therein; (b) any misrepresentation or breach of any representation or warranty made by the Investor in this Agreement or any instrument or document contemplated hereby or thereby executed by the Investor; or (c) any breach of any covenant, agreement or obligation of the Investor contained in this Agreement or any other certificate, instrument or document contemplated hereby or thereby executed by the Investor. To the extent that the foregoing undertaking by the Investor may be unenforceable under Applicable Laws, the Investor shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities, which is permissible under Applicable Laws.

  • Termination by the Sellers The Sellers may terminate the Agreement in the event either Purchaser or the Guarantor (if any of the proceedings with respect to the Guarantor in the following clauses (i) through (iv) below would reasonably be expected to impair the ability of either Purchaser to perform its obligations under the Agreement (including Article 8 of the Agreement and this Annex A) fully and on a timely basis) (i) becomes the subject of any bankruptcy or other proceeding relating to its liquidation or insolvency (if not dismissed within sixty (60) days of initial filing), or is the subject of a receivership or conservatorship, (ii) files a voluntary petition in bankruptcy or similar proceeding or admits in writing its inability to pay its debts as they become due, (iii) makes a general assignment for the benefit of creditors, or (iv) files a petition or an answer seeking reorganization or an arrangement with creditors.

  • Cooperation by the Indemnified Party The Indemnified Party shall reasonably cooperate with and assist the Indemnifying Party in determining the validity of any claim for indemnity by the Indemnified Party and in defending against a Third-Party Claim. In connection with any fact, matter, event or circumstance that may give rise to a claim against any Indemnifying Party under this Agreement, the Indemnified Party shall ensure that each relevant member of the Indemnified Party’s Group: (i) shall preserve all material evidence relevant to the claim to the extent within the control of the Indemnified Party’s Group, (ii) shall allow the Indemnifying Party to investigate the fact, matter, event or circumstance alleged to give rise to such claim and whether and to what extent any amount is payable in respect of such claim, and (iii) shall (at the Indemnified Party’s expense) disclose to the Indemnifying Party all material of which it is aware which relates to the claim and provide, and procure that any other relevant members of the Indemnified Party’s Group shall provide (at the Indemnified Party’s expense), all such information and assistance, including reasonable access to premises and personnel, and the right to examine and copy or photograph any assets, accounts, documents and records, as the Indemnifying Party may reasonably request, subject to the Indemnifying Party agreeing in such form as the Indemnified Party may reasonably require to keep all such information confidential and to use it only for the purpose of investigating and defending the claim in question; provided that the foregoing shall not require the Indemnified Party to disclose any documents or information that may be reasonably expected to result in a violation of applicable Law or the loss or waiver of any attorney-client, work product or similar legal privilege; provided further that the Indemnified Party and the Indemnifying Party shall work in good faith to put in place appropriate substitute disclosure arrangements to permit such disclosure without such violation, loss or waiver.

  • Notification by the Indemnified Party If any Indemnified Party becomes aware of any fact, matter or circumstance that has given or may reasonably be expected to give rise to a claim for indemnification under this Article 8, the Indemnified Party shall at its own expense promptly (and in no event later than ten (10) Business Days after the applicable Indemnified Party becoming so aware) notify the Indemnifying Party in writing of any claim in respect of which indemnity may be sought under this Article 8 (including any pending or threatened claim or demand by a third party (including any Tax Authority)), that the applicable Indemnified Party has determined has given or could reasonably give rise to a right of indemnification under this Agreement (including a pending or threatened claim or demand asserted by a third party against the Indemnified Party, whether by litigation, by arbitration, as a result of an investigation, or otherwise (each, a “Third-Party Claim”)), setting out the provisions under this Agreement on which such claim is based, and such other information as is reasonably necessary to enable the Indemnifying Party to assess the merits of the potential claim, to act to preserve evidence and to make such provision as it may consider necessary (including details of the legal and factual basis of the claim and the evidence on which the party relies (including where the claim is the result of a Third-Party Claim, evidence of the Third-Party Claim) and, to the extent reasonably ascertainable, setting out its estimate of the amount of Losses which are, or are to be, the subject of the claim) and the Indemnified Party shall keep the Indemnifying Party reasonably and promptly informed of any developments (including additional information which may become available to it) in respect of such facts, matters or circumstances; provided, however, that any failure or delay in providing such notice shall not release the Indemnifying Party from any of its obligations under this Article 8 except to the extent the Indemnifying Party is prejudiced by such failure or delay.

  • Termination by the University i) The university may terminate this agreement under the following circumstances:

  • Termination by the Company This Agreement may be terminated and the Merger Transactions abandoned at any time before the Acceptance Time by the Company: (a) in order to enter into an Acquisition Agreement pursuant to and in accordance with Section 5.3(c), so long as concurrently with such termination the Company pays the Expense Reimbursement under Section 7.6(b)(i); (b) if Parent or Merger Sub breaches any of their respective representations or warranties, or fails to perform any of their respective covenants or agreements contained in this Agreement, and which breach or failure (i) would, individually or when aggregated with any such other breaches of failures, result in a Parent Material Adverse Effect and (ii) by its nature cannot be cured or has not been cured by Parent or Merger Sub, as applicable, by the earlier of (A) the Outside Date and (B) the date that is twenty (20) Business Days after Xxxxxx’s receipt of written notice of such breach from the Company, but only so long as the Company is not then in material breach of its representations or warranties or materially failing to perform its covenants or agreements contained in this Agreement in a manner that would allow Parent to terminate this Agreement under Section 7.3(b); or (c) upon prior written notice to Parent, if Xxxxxx Sub fails to commence the Offer in accordance with the terms of this Agreement hereof on or prior to the fifteenth (15th) Business Day following the date hereof or if Merger Sub fails to consummate the Offer when required to do so in accordance with the terms of this Agreement; provided, however, that the right to terminate this Agreement pursuant to this Section 7.4(c) shall not be available to the Company if the Company is in breach of any representation, warranty, covenant or agreement set forth in this Agreement that has been the proximate cause of, or resulted in, Merger Sub’s failure to commence or consummate the Offer in accordance with the terms of this Agreement.

  • Cooperation by the Company If any Shareholder shall transfer any Registrable Securities pursuant to Rule 144, the Company shall cooperate, to the extent commercially reasonable, with such Shareholder and shall provide to such Shareholder such information as such Shareholder shall reasonably request.

  • TERMINATION BY THE CONTRACTOR If the Work is stopped for a period of thirty days under an order of any court or other public authority having jurisdiction, or as a result of an act of government, such as a declaration of a national emergency making materials unavailable, through no act or fault of the Contractor or a Subcontractor or their agents or employees or any other persons performing any of the Work under a contract with the Contractor, or if the Work should be stopped for a period of thirty days by the Contractor because the Architect has not issued a Certificate for Payment as provided in Paragraph 9.7 of these General Conditions or because the State has not made payment thereon as provided in Paragraph 9.7, then the Contractor may, upon seven additional days written notice to the State and the Architect, terminate the Contract and recover from the State payment for all Work executed and for any proven loss sustained upon any materials, equipment, tools, construction equipment and machinery, including reasonable profit and damages.

  • Indemnification by the Investors Each Investor agrees, severally but not jointly, to indemnify and hold harmless, to the fullest extent permitted by law, the Company, its directors, officers, employees, stockholders and each person who controls the Company (within the meaning of the 0000 Xxx) against any losses, claims, damages, liabilities and expense (including reasonable attorney fees) resulting from any untrue statement of a material fact or any omission of a material fact required to be stated in the Registration Statement or Prospectus or preliminary Prospectus or amendment or supplement thereto or necessary to make the statements therein not misleading, to the extent, but only to the extent that such untrue statement or omission is contained in any information furnished in writing by such Investor to the Company specifically for inclusion in such Registration Statement or Prospectus or amendment or supplement thereto. In no event shall the liability of an Investor be greater in amount than the dollar amount of the proceeds (net of all expense paid by such Investor in connection with any claim relating to this Section 6 and the amount of any damages such Investor has otherwise been required to pay by reason of such untrue statement or omission) received by such Investor upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!